Compounds > pyrroles
Page last updated: 2024-08-18

pyrroles and Abdominal Neoplasms

pyrroles has been researched along with Abdominal Neoplasms in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bourcier, ME; Vinik, AI1
Barney, BM; Bauer, HJ; Laack, NN; Macdonald, OK; Markovic, SN; Miller, RC; Olivier, KR; Sarkaria, JN1
Bargman, JM; Oreopoulos, DG; Simons, M; Tapiawala, SN1
MCAFEE, J; RUBENFELD, S; WINKELMAN, J1
Arnaud, L; Bousquet, G; Kerob, D; Lebbe, C; Madelaine, I; Sarandi, F; Schartz, NE; Verola, O1

Other Studies

5 other study(ies) available for pyrroles and Abdominal Neoplasms

ArticleYear
Sunitinib for the treatment of metastatic paraganglioma and vasoactive intestinal polypeptide-producing tumor (VIPoma).
    Pancreas, 2013, Volume: 42, Issue:2

    Topics: Abdominal Neoplasms; Aged; Antineoplastic Agents; Biomarkers, Tumor; Child; Drug Administration Schedule; Female; Humans; Indoles; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Pancreatic Neoplasms; Paraganglioma; Protein Kinase Inhibitors; Pyrroles; Sunitinib; Time Factors; Treatment Outcome; Vipoma

2013
Increased bowel toxicity in patients treated with a vascular endothelial growth factor inhibitor (VEGFI) after stereotactic body radiation therapy (SBRT).
    International journal of radiation oncology, biology, physics, 2013, Sep-01, Volume: 87, Issue:1

    Topics: Abdominal Neoplasms; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antibodies, Monoclonal, Humanized; Bevacizumab; Duodenal Diseases; Humans; Indazoles; Indoles; Intestinal Diseases; Middle Aged; Niacinamide; Phenylurea Compounds; Pyrimidines; Pyrroles; Radiography; Radiosurgery; Radiotherapy Dosage; Receptors, Vascular Endothelial Growth Factor; Retrospective Studies; Sorafenib; Stomach Ulcer; Sulfonamides; Sunitinib; Ulcer

2013
Prolonged use of the tyrosine kinase inhibitor in a peritoneal dialysis patient with metastatic renal cell carcinoma: possible beneficial effects on peritoneal membrane and peritonitis rates.
    International urology and nephrology, 2009, Volume: 41, Issue:2

    Topics: Abdominal Neoplasms; Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Drug Administration Schedule; Female; Humans; Indoles; Kidney Neoplasms; Middle Aged; Peritoneal Dialysis; Peritonitis; Protein-Tyrosine Kinases; Pyrroles; Sunitinib

2009
THE METABOLISM AND EXCRETION OF CO57 TETRAPHENYLPORPHINESULFONATE IN CANCER PATIENTS.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1964, Volume: 5

    Topics: Abdominal Neoplasms; Brain Neoplasms; Cobalt Isotopes; Humans; Metabolism; Neoplasms; Pyrroles; Radiometry

1964
Transient sunitinib-induced coma in a patient with fibromyxoid sarcoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Mar-20, Volume: 26, Issue:9

    Topics: Abdominal Neoplasms; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Coma; Fatal Outcome; Female; Fibroma; Fibrosarcoma; Humans; Indoles; Liver Neoplasms; Middle Aged; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrroles; Sunitinib; Treatment Failure

2008